HOSPITAL MANAGEMENT COMPANIES – AUSTRALIA

Ramsay plays down Brexit risks as recovery starts to show

roymorgansocial Leave a comment

Original article by Carrie LaFrenz
The Australian Financial Review – Page: 17 & 22 : 1-Mar-19

Ramsay Health Care has reported a 2018-19 interim net profit of $270.1 million, up 9.6 per cent, while revenue rose by 14.9 per cent to $5.12 billion. Meanwhile, CEO Craig McNally says its UK division is beginning to show some promising signs, although Brexit could pose some short-term challenges. Ramsay’s UK unit generates less than 10 per cent of the private hospital operator’s revenue. McNally says that staffing and supply would be the two biggest areas where Brexit would impact on its UK division.

CORPORATES
RAMSAY HEALTH CARE LIMITED – ASX RHC, CAPIO AB, MONTGOMERY INVESTMENT MANAGEMENT PTY LTD

Healthscope offloads pathology business

roymorgansocial Leave a comment

Original article by Tim Binsted
The Australian Financial Review – Page: 15 : 24-Jun-15

Crescent Capital has paid $A105m for the pathology assets of Australian-listed Healthscope, with the deal comprising a cash component of $A92.5m and a $A12.5m promissory note. Healthscope CEO Robert Cooke says the deal will allow the group to focus on its core business of private hospitals. In addition to Healthscope’s pathology laboratories and collection centres, the private equity firm will also buy a portfolio of six skin clinic.

CORPORATES
HEALTHSCOPE LIMITED – ASX HSO, CRESCENT CAPITAL PARTNERS LIMITED, SONIC HEALTHCARE LIMITED – ASX SHL, PRIMARY HEALTH CARE LIMITED – ASX PRY, TPG CAPITAL LP, THE CARLYLE GROUP, CLSA AUSTRALIA PTY LTD, NATIONAL DENTAL CARE PTY LTD, LIFEHEALTHCARE GROUP LIMITED – ASX LHC, NATIONAL HEARING CARE LIMITED, SOUTHERN SUN SKIN CANCER CLINICS

‘Unsolicited offers’ for Healthscope arm

roymorgansocial Leave a comment

Original article by Tim Binsted
The Australian Financial Review – Page: 21 : 26-May-15

The pathology division of Healthscope boasts a market share of about 13 per cent, but its EBITDA for the first half of 2014-15 fell by 23 per cent to $A9.3m. Factors such as competition in the sector and a reduction in Medicare fees have also affected revenue. Healthscope CEO Robert Cooke says the group is often is approached about selling parts of its business but stresses that a sale process for the pathology unit is not underway.

CORPORATES
HEALTHSCOPE LIMITED – ASX HSO, SONIC HEALTHCARE LIMITED – ASX SHL, PRIMARY HEALTH CARE LIMITED – ASX PRY, CLSA AUSTRALIA PTY LTD, CRESCENT CAPITAL PARTNERS LIMITED, AUSTRALIA. DEPT OF HUMAN SERVICES. MEDICARE AUSTRALIA, AUSTRALIAN COMPETITION AND CONSUMER COMMISSION

Boomers will keep Ramsay’s hospital beds full

roymorgansocial Leave a comment

Original article by Jessica Gardner
The Australian Financial Review – Page: 13 & 18 : 27-Feb-15

Australian-listed Ramsay Health Care has posted a 2014-15 interim net profit of $A191.4m, which is 21.3 per cent higher than previously. The private hospitals group recorded revenue of $A3.3bn for the half-year, an increase of 41.6 per cent. Its Australian division’s EBIT was up 12.6 per cent at $A282.8m and revenue was eight per cent higher at $A2bn. Ramsay expects core net profit for the full year to be 18-20 per cent higher than previously

CORPORATES
RAMSAY HEALTH CARE LIMITED – ASX RHC, GENERALE DE SANTE SA, AUSTRALIAN LABOR PARTY, HYPERION ASSET MANAGEMENT LIMITED

Full beds limit Healthscope’s growth

roymorgansocial Leave a comment

Original article by Jessica Gardner
The Australian Financial Review – Page: 17 : 25-Feb-15

Healthscope has posted a 2014-15 interim net profit of $A58.6m, after a loss for the previous corresponding period. The group’s hospital revenue rose by 6.3 per cent to $A938.9m. CEO Robert Cooke notes that Healthscope’s existing hospitals are overstretched, with just 23 new beds added in the last 18 months. The group aims to open nearly 1,000 additional beds in the next three years

CORPORATES
HEALTHSCOPE LIMITED – ASX HSO, HYPERION ASSET MANAGEMENT LIMITED

End of an era for Primary Health Care as founder ‘Dr Ed’ Bateman retires

roymorgansocial Leave a comment

Original article by Damon Kitney
The Australian – Page: 19 : 25-Nov-14

The 2014 AGM of Primary Health Care will hear that founder and MD Edmund Bateman is planning to retire soon, due to ill health. The medical centres as well as pathology and radiology services operator has engaged Sheldon Harris Management Consulting to identify a successor, and among the internal frontrunners are sons Henry and James Bateman. Their father has been at the helm for some three decades, and suffered his main setback when the acquisition of rival Symbion coincided with the start of the global financial crisis in 2008

CORPORATES
PRIMARY HEALTH CARE LIMITED – ASX PRY, SYMBION HEALTH LIMITED, AUSBIL DEXIA LIMITED, UBS HOLDINGS PTY LTD, LIBERAL PARTY OF AUSTRALIA, SWIMMING AUSTRALIA, SHELDON-HARRIS PTY LTD, RUSSELL REYNOLDS ASSOCIATES INCORPORATED, SPENCER STUART AND ASSOCIATES

$3.6b float boosts share confidence

roymorgansocial Leave a comment

Original article by Jessica Gardner
The Australian Financial Review – Page: 15 & 20 : 29-Jul-14

Healthscope’s stock closed $A0.11 higher at $A2.21 on 28 July 2014, after dipping to $A2.09 early in its debut trading session The stock was issued at $A2.10 in a $A3.6bn IPO. Private equity firms TPG Capital and The Carlyle Group will retain their 38 per cent stake until Healthscope releases its financial results for fiscal 2015. The two firms had paid $A2.7bn for the private hospitals operator in 2010

CORPORATES
HEALTHSCOPE LIMITED – ASX HSO, TPG CAPITAL LP, THE CARLYLE GROUP, AURIZON HOLDINGS LIMITED – ASX AZJ, MEDIBANK PRIVATE LIMITED, STANDARD AND POOR’S ASX 200 INDEX, RAMSAY HEALTH CARE LIMITED – ASX RHC

Healthscope price splits fund managers

roymorgansocial Leave a comment

Original article by Jemima Whyte
The Australian Financial Review – Page: 13 : 21-Jul-14

Shares in Healthscope will be priced within the range of $A1.76 and $A2.29 apiece in an IPO that will be worth around $A2.5bn. The company is being floated by TPG Capital and The Carlyle Group, but Anton Tagliaferro of Investors Mutual says investors should be cautious about IPOs that are backed by private equity firms. He believes that Healthscope’s shares are overvalued and says Investors Mutual will not be buying stock in the float

CORPORATES
HEALTHSCOPE LIMITED – ASX HSO, INVESTORS MUTUAL LIMITED, TPG CAPITAL LP, THE CARLYLE GROUP, EQUITY TRUSTEES LIMITED – ASX EQT, PENGANA CAPITAL LIMITED, RAMSAY HEALTH CARE LIMITED – ASX RHC